ArticleHepatology communications2019

OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma.

Yosuke Ashizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.